E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

European Organisation for Research and Treatment of Cancer (EORTC)

Status: Enrolling

Conditions: Cancer

Study type: Observational

Funder types: NETWORK

Identifiers

NCT03818503

EORTC-1811

Details and patient eligibility

About

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Pathologically confirmed cancer.
• Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
• Planned use of radiotherapy
• Eligibility of the patient confirmed for at least one cohort confirmed
• Patients of 12 years and older

Trial design

2,000 participants in 2 patient groups

OligoCare

Description:

Patients with oligometastatic disease treated with radical radiotherapy

ReCare

Description:

Patients treated with high-dose Re-irradiation